310 related articles for article (PubMed ID: 34440652)
1. Long Non-Coding RNAs Involved in Progression of Non-Alcoholic Fatty Liver Disease to Steatohepatitis.
Atanasovska B; Rensen SS; Marsman G; Shiri-Sverdlov R; Withoff S; Kuipers F; Wijmenga C; van de Sluis B; Fu J
Cells; 2021 Jul; 10(8):. PubMed ID: 34440652
[TBL] [Abstract][Full Text] [Related]
2. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
3. Metformin-Induced Changes of the Coding Transcriptome and Non-Coding RNAs in the Livers of Non-Alcoholic Fatty Liver Disease Mice.
Guo J; Zhou Y; Cheng Y; Fang W; Hu G; Wei J; Lin Y; Man Y; Guo L; Sun M; Cui Q; Li J
Cell Physiol Biochem; 2018; 45(4):1487-1505. PubMed ID: 29466788
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
6. ATP Citrate Lyase and LncRNA NONMMUT010685 Play Crucial Role in Nonalcoholic Fatty Liver Disease Based on Analysis of Microarray Data.
Ma TT; Huang C; Ni Y; Yang Y; Li J
Cell Physiol Biochem; 2018; 51(2):871-885. PubMed ID: 30466110
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Chi X; Qu N; Wang C
Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[Formula: see text]B/JNK pathway by endoplasmic reticulum stress.
Ye L; Zhao D; Xu Y; Lin J; Xu J; Wang K; Ye Z; Luo Y; Liu S; Yang H
J Transl Med; 2021 Mar; 19(1):101. PubMed ID: 33750416
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conservation of long non-coding RNAs in non-alcoholic fatty liver disease.
Rohilla S; Awasthi A; Kaur S; Puria R
Life Sci; 2021 Jan; 264():118560. PubMed ID: 33045214
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
Chen Y; Huang H; Xu C; Yu C; Li Y
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
12. Hesperetin ameliorates hepatic oxidative stress and inflammation
Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
[TBL] [Abstract][Full Text] [Related]
13. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
14. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
Tan DY; Shi HY; Li CP; Zhong XL; Kang M
World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.
Leti F; Legendre C; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Transl Res; 2017 Dec; 190():25-39.e21. PubMed ID: 28993096
[TBL] [Abstract][Full Text] [Related]
17. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
18. A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis.
Atanasovska B; Rensen SS; van der Sijde MR; Marsman G; Kumar V; Jonkers I; Withoff S; Shiri-Sverdlov R; Greve JWM; Faber KN; Moshage H; Wijmenga C; van de Sluis B; Hofker MH; Fu J
Hepatology; 2017 Sep; 66(3):794-808. PubMed ID: 28073183
[TBL] [Abstract][Full Text] [Related]
19. Lipid accumulation stimulates the cap-independent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis.
Siculella L; Tocci R; Rochira A; Testini M; Gnoni A; Damiano F
Biochim Biophys Acta; 2016 May; 1861(5):471-81. PubMed ID: 26869449
[TBL] [Abstract][Full Text] [Related]
20. Glutathione disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty liver disease.
Dou X; Li S; Hu L; Ding L; Ma Y; Ma W; Chai H; Song Z
Exp Mol Med; 2018 Apr; 50(4):1-16. PubMed ID: 29622764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
